The Australian Regenerative Medicine Institute officially opened on April 2009. It is a $153 million medical research centre based at the Monash University Clayton Campus.

The institute was established through a joint venture between Monash University and the Victorian Government to deliver the next generation of discoveries in regenerative medicine.

ARMI is one of the world’s largest regenerative medicine and stem cell research centres.  The focus of the research is to ascertain the mechanisms associated with the regenerative process by studying how life is formed, how it develops and how it regenerates – all components that are vital to regenerative medicine.

The aim of ARMI is to create the technology and therapies that will be able to prevent, halt and reverse damage to organs and tissues due to disease, injury and genetic conditions. This will provide treatments for conditions such as neurodegenerative disorders, autoimmune diseases, diabetes type 1, musculo-skeletal conditions and cardiovascular diseases.

The foundation director is Professor Nadia Rosenthal, who brings an incredible wealth of knowledge from her experience at the European Molecule Biology Laboratory (EMBL) and Harvard Medical School. When Rosenthal was at Harvard, she was part of the research group that discovered the gene responsible for insulin.

Today, ARMI is a hub for brilliant regenerative research, which have translated into numerous high impact publications and which have strong commercialisation potential. ARMI is young, largely consisting of highly capable early to mid career scientists. ARMI’s culture is defined by the wide breadth of cultures across multiple nations that sculpts its unique character and accomplished research.

In 2016, Peter Currie took on the new director role at ARMI.